English
简体中文
Total: £ 56.28
Published Date: 2025-11-10 | Pages: 134 | Tables: 137 | Medical Care
The global Gene Therapy CRO Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Gene therapy Contract Research Organization (CRO) services encompass a range of specialized offerings tailored to support the development and execution of preclinical and clinical research programs for gene therapy products. These services are designed to assist biopharmaceutical companies, academic institutions, and government agencies in advancing the development of gene therapy treatments for various diseases and medical conditions.
From a downstream perspective, SMBs accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Gene Therapy CRO Services leading manufacturers including Labcorp, IQVIA Biotech, PPD, Medpace, Veristat, Parexel, Charles River Laboratories, Catalent Pharma Solutions, Premier Research, Catalent, etc., dominate supply; the top five capture approximately % of global revenue, with Labcorp leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Gene Therapy CRO Services market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Labcorp
IQVIA Biotech
PPD
Medpace
Veristat
Parexel
Charles River Laboratories
Catalent Pharma Solutions
Premier Research
Catalent
Vial
Noble Life Sciences
Ergomed
Segment by Type
Preclinical CRO
Clinical CRO
Segment by Application
SMBs
Large Companies
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Gene Therapy CRO Services study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Gene Therapy CRO Services: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Gene Therapy CRO Services Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Preclinical CRO
1.2.3 Clinical CRO
1.3 Market Segmentation by Application
1.3.1 Global Gene Therapy CRO Services Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 SMBs
1.3.3 Large Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gene Therapy CRO Services Revenue Estimates and Forecasts 2020-2031
2.2 Global Gene Therapy CRO Services Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Gene Therapy CRO Services Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Gene Therapy CRO Services Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Preclinical CRO Market Size by Players
3.3.2 Clinical CRO Market Size by Players
3.4 Global Gene Therapy CRO Services Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Gene Therapy CRO Services Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Gene Therapy CRO Services Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Gene Therapy CRO Services Market Size by Type (2020-2031)
6.4 North America Gene Therapy CRO Services Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Gene Therapy CRO Services Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Gene Therapy CRO Services Market Size by Type (2020-2031)
7.4 Europe Gene Therapy CRO Services Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Gene Therapy CRO Services Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Gene Therapy CRO Services Market Size by Type (2020-2031)
8.4 Asia-Pacific Gene Therapy CRO Services Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Gene Therapy CRO Services Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Gene Therapy CRO Services Market Size by Type (2020-2031)
9.4 Central and South America Gene Therapy CRO Services Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Gene Therapy CRO Services Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Gene Therapy CRO Services Market Size by Type (2020-2031)
10.4 Middle East and Africa Gene Therapy CRO Services Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Gene Therapy CRO Services Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Labcorp
11.1.1 Labcorp Corporation Information
11.1.2 Labcorp Business Overview
11.1.3 Labcorp Gene Therapy CRO Services Product Features and Attributes
11.1.4 Labcorp Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.1.5 Labcorp Gene Therapy CRO Services Revenue by Product in 2024
11.1.6 Labcorp Gene Therapy CRO Services Revenue by Application in 2024
11.1.7 Labcorp Gene Therapy CRO Services Revenue by Geographic Area in 2024
11.1.8 Labcorp Gene Therapy CRO Services SWOT Analysis
11.1.9 Labcorp Recent Developments
11.2 IQVIA Biotech
11.2.1 IQVIA Biotech Corporation Information
11.2.2 IQVIA Biotech Business Overview
11.2.3 IQVIA Biotech Gene Therapy CRO Services Product Features and Attributes
11.2.4 IQVIA Biotech Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.2.5 IQVIA Biotech Gene Therapy CRO Services Revenue by Product in 2024
11.2.6 IQVIA Biotech Gene Therapy CRO Services Revenue by Application in 2024
11.2.7 IQVIA Biotech Gene Therapy CRO Services Revenue by Geographic Area in 2024
11.2.8 IQVIA Biotech Gene Therapy CRO Services SWOT Analysis
11.2.9 IQVIA Biotech Recent Developments
11.3 PPD
11.3.1 PPD Corporation Information
11.3.2 PPD Business Overview
11.3.3 PPD Gene Therapy CRO Services Product Features and Attributes
11.3.4 PPD Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.3.5 PPD Gene Therapy CRO Services Revenue by Product in 2024
11.3.6 PPD Gene Therapy CRO Services Revenue by Application in 2024
11.3.7 PPD Gene Therapy CRO Services Revenue by Geographic Area in 2024
11.3.8 PPD Gene Therapy CRO Services SWOT Analysis
11.3.9 PPD Recent Developments
11.4 Medpace
11.4.1 Medpace Corporation Information
11.4.2 Medpace Business Overview
11.4.3 Medpace Gene Therapy CRO Services Product Features and Attributes
11.4.4 Medpace Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.4.5 Medpace Gene Therapy CRO Services Revenue by Product in 2024
11.4.6 Medpace Gene Therapy CRO Services Revenue by Application in 2024
11.4.7 Medpace Gene Therapy CRO Services Revenue by Geographic Area in 2024
11.4.8 Medpace Gene Therapy CRO Services SWOT Analysis
11.4.9 Medpace Recent Developments
11.5 Veristat
11.5.1 Veristat Corporation Information
11.5.2 Veristat Business Overview
11.5.3 Veristat Gene Therapy CRO Services Product Features and Attributes
11.5.4 Veristat Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.5.5 Veristat Gene Therapy CRO Services Revenue by Product in 2024
11.5.6 Veristat Gene Therapy CRO Services Revenue by Application in 2024
11.5.7 Veristat Gene Therapy CRO Services Revenue by Geographic Area in 2024
11.5.8 Veristat Gene Therapy CRO Services SWOT Analysis
11.5.9 Veristat Recent Developments
11.6 Parexel
11.6.1 Parexel Corporation Information
11.6.2 Parexel Business Overview
11.6.3 Parexel Gene Therapy CRO Services Product Features and Attributes
11.6.4 Parexel Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.6.5 Parexel Recent Developments
11.7 Charles River Laboratories
11.7.1 Charles River Laboratories Corporation Information
11.7.2 Charles River Laboratories Business Overview
11.7.3 Charles River Laboratories Gene Therapy CRO Services Product Features and Attributes
11.7.4 Charles River Laboratories Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.7.5 Charles River Laboratories Recent Developments
11.8 Catalent Pharma Solutions
11.8.1 Catalent Pharma Solutions Corporation Information
11.8.2 Catalent Pharma Solutions Business Overview
11.8.3 Catalent Pharma Solutions Gene Therapy CRO Services Product Features and Attributes
11.8.4 Catalent Pharma Solutions Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.8.5 Catalent Pharma Solutions Recent Developments
11.9 Premier Research
11.9.1 Premier Research Corporation Information
11.9.2 Premier Research Business Overview
11.9.3 Premier Research Gene Therapy CRO Services Product Features and Attributes
11.9.4 Premier Research Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.9.5 Premier Research Recent Developments
11.10 Catalent
11.10.1 Catalent Corporation Information
11.10.2 Catalent Business Overview
11.10.3 Catalent Gene Therapy CRO Services Product Features and Attributes
11.10.4 Catalent Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Vial
11.11.1 Vial Corporation Information
11.11.2 Vial Business Overview
11.11.3 Vial Gene Therapy CRO Services Product Features and Attributes
11.11.4 Vial Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.11.5 Vial Recent Developments
11.12 Noble Life Sciences
11.12.1 Noble Life Sciences Corporation Information
11.12.2 Noble Life Sciences Business Overview
11.12.3 Noble Life Sciences Gene Therapy CRO Services Product Features and Attributes
11.12.4 Noble Life Sciences Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.12.5 Noble Life Sciences Recent Developments
11.13 Ergomed
11.13.1 Ergomed Corporation Information
11.13.2 Ergomed Business Overview
11.13.3 Ergomed Gene Therapy CRO Services Product Features and Attributes
11.13.4 Ergomed Gene Therapy CRO Services Revenue and Gross Margin (2020-2025)
11.13.5 Ergomed Recent Developments
12 Gene Therapy CRO ServicesIndustry Chain Analysis
12.1 Gene Therapy CRO Services Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Gene Therapy CRO Services Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Gene Therapy CRO Services Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Gene Therapy CRO Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Gene Therapy CRO Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Gene Therapy CRO Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Gene Therapy CRO Services Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Gene Therapy CRO Services Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Gene Therapy CRO Services Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Gene Therapy CRO Services Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Gene Therapy CRO Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy CRO Services as of 2024)
Table 11. Global Gene Therapy CRO Services Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Gene Therapy CRO Services Companies Headquarters
Table 13. Global Gene Therapy CRO Services Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Gene Therapy CRO Services Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Gene Therapy CRO Services Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Gene Therapy CRO Services Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Gene Therapy CRO Services Revenue by Application (2026-2031) & (US$ Million)
Table 21. Gene Therapy CRO Services High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Gene Therapy CRO Services Growth Accelerators and Market Barriers
Table 25. North America Gene Therapy CRO Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Gene Therapy CRO Services Growth Accelerators and Market Barriers
Table 27. Europe Gene Therapy CRO Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Gene Therapy CRO Services Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Gene Therapy CRO Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Gene Therapy CRO Services Investment Opportunities and Key Challenges
Table 31. Central and South America Gene Therapy CRO Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Gene Therapy CRO Services Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Gene Therapy CRO Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Labcorp Corporation Information
Table 35. Labcorp Description and Major Businesses
Table 36. Labcorp Product Features and Attributes
Table 37. Labcorp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Labcorp Revenue Proportion by Product in 2024
Table 39. Labcorp Revenue Proportion by Application in 2024
Table 40. Labcorp Revenue Proportion by Geographic Area in 2024
Table 41. Labcorp Gene Therapy CRO Services SWOT Analysis
Table 42. Labcorp Recent Developments
Table 43. IQVIA Biotech Corporation Information
Table 44. IQVIA Biotech Description and Major Businesses
Table 45. IQVIA Biotech Product Features and Attributes
Table 46. IQVIA Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. IQVIA Biotech Revenue Proportion by Product in 2024
Table 48. IQVIA Biotech Revenue Proportion by Application in 2024
Table 49. IQVIA Biotech Revenue Proportion by Geographic Area in 2024
Table 50. IQVIA Biotech Gene Therapy CRO Services SWOT Analysis
Table 51. IQVIA Biotech Recent Developments
Table 52. PPD Corporation Information
Table 53. PPD Description and Major Businesses
Table 54. PPD Product Features and Attributes
Table 55. PPD Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. PPD Revenue Proportion by Product in 2024
Table 57. PPD Revenue Proportion by Application in 2024
Table 58. PPD Revenue Proportion by Geographic Area in 2024
Table 59. PPD Gene Therapy CRO Services SWOT Analysis
Table 60. PPD Recent Developments
Table 61. Medpace Corporation Information
Table 62. Medpace Description and Major Businesses
Table 63. Medpace Product Features and Attributes
Table 64. Medpace Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Medpace Revenue Proportion by Product in 2024
Table 66. Medpace Revenue Proportion by Application in 2024
Table 67. Medpace Revenue Proportion by Geographic Area in 2024
Table 68. Medpace Gene Therapy CRO Services SWOT Analysis
Table 69. Medpace Recent Developments
Table 70. Veristat Corporation Information
Table 71. Veristat Description and Major Businesses
Table 72. Veristat Product Features and Attributes
Table 73. Veristat Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Veristat Revenue Proportion by Product in 2024
Table 75. Veristat Revenue Proportion by Application in 2024
Table 76. Veristat Revenue Proportion by Geographic Area in 2024
Table 77. Veristat Gene Therapy CRO Services SWOT Analysis
Table 78. Veristat Recent Developments
Table 79. Parexel Corporation Information
Table 80. Parexel Description and Major Businesses
Table 81. Parexel Product Features and Attributes
Table 82. Parexel Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Parexel Recent Developments
Table 84. Charles River Laboratories Corporation Information
Table 85. Charles River Laboratories Description and Major Businesses
Table 86. Charles River Laboratories Product Features and Attributes
Table 87. Charles River Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Charles River Laboratories Recent Developments
Table 89. Catalent Pharma Solutions Corporation Information
Table 90. Catalent Pharma Solutions Description and Major Businesses
Table 91. Catalent Pharma Solutions Product Features and Attributes
Table 92. Catalent Pharma Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Catalent Pharma Solutions Recent Developments
Table 94. Premier Research Corporation Information
Table 95. Premier Research Description and Major Businesses
Table 96. Premier Research Product Features and Attributes
Table 97. Premier Research Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Premier Research Recent Developments
Table 99. Catalent Corporation Information
Table 100. Catalent Description and Major Businesses
Table 101. Catalent Product Features and Attributes
Table 102. Catalent Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Catalent Recent Developments
Table 104. Vial Corporation Information
Table 105. Vial Description and Major Businesses
Table 106. Vial Product Features and Attributes
Table 107. Vial Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Vial Recent Developments
Table 109. Noble Life Sciences Corporation Information
Table 110. Noble Life Sciences Description and Major Businesses
Table 111. Noble Life Sciences Product Features and Attributes
Table 112. Noble Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Noble Life Sciences Recent Developments
Table 114. Ergomed Corporation Information
Table 115. Ergomed Description and Major Businesses
Table 116. Ergomed Product Features and Attributes
Table 117. Ergomed Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Ergomed Recent Developments
Table 119. Raw Materials Key Suppliers
Table 120. Distributors List
Table 121. Market Trends and Market Evolution
Table 122. Market Drivers and Opportunities
Table 123. Market Challenges, Risks, and Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Therapy CRO Services Product Picture
Figure 2. Global Gene Therapy CRO Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Preclinical CRO Product Picture
Figure 4. Clinical CRO Product Picture
Figure 5. Global Gene Therapy CRO Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. SMBs
Figure 7. Large Companies
Figure 8. Gene Therapy CRO Services Report Years Considered
Figure 9. Global Gene Therapy CRO Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 11. Global Gene Therapy CRO Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Gene Therapy CRO Services Revenue Market Share by Region (2020-2031)
Figure 13. Global Gene Therapy CRO Services Revenue Market Share Ranking (2024)
Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 15. Preclinical CRO Revenue Market Share by Player in 2024
Figure 16. Clinical CRO Revenue Market Share by Player in 2024
Figure 17. Global Gene Therapy CRO Services Revenue Market Share by Type (2020-2031)
Figure 18. Global Gene Therapy CRO Services Revenue Market Share by Application (2020-2031)
Figure 19. North America Gene Therapy CRO Services Revenue YoY (2020-2031) & (US$ Million)
Figure 20. North America Top 5 Players Gene Therapy CRO Services Revenue (US$ Million) in 2024
Figure 21. North America Gene Therapy CRO Services Revenue (US$ Million) by Type (2020 - 2031)
Figure 22. North America Gene Therapy CRO Services Revenue (US$ Million) by Application (2020-2031)
Figure 23. US Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 24. Canada Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 25. Mexico Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 26. Europe Gene Therapy CRO Services Revenue YoY (2020-2031) & (US$ Million)
Figure 27. Europe Top 5 Players Gene Therapy CRO Services Revenue (US$ Million) in 2024
Figure 28. Europe Gene Therapy CRO Services Revenue (US$ Million) by Type (2020-2031)
Figure 29. Europe Gene Therapy CRO Services Revenue (US$ Million) by Application (2020-2031)
Figure 30. Germany Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 31. France Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 32. U.K. Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 33. Italy Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 34. Russia Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Gene Therapy CRO Services Revenue YoY (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Top 8 Players Gene Therapy CRO Services Revenue (US$ Million) in 2024
Figure 37. Asia-Pacific Gene Therapy CRO Services Revenue (US$ Million) by Type (2020-2031)
Figure 38. Asia-Pacific Gene Therapy CRO Services Revenue (US$ Million) by Application (2020-2031)
Figure 39. Indonesia Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 40. Japan Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 41. South Korea Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 42. Australia Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 43. India Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 44. Indonesia Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 45. Vietnam Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 46. Malaysia Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 47. Philippines Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 48. Singapore Gene Therapy CRO Services Revenue (2020-2031) & (US$ Million)
Figure 49. Central and South America Gene Therapy CRO Services Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Central and South America Top 5 Players Gene Therapy CRO Services Revenue (US$ Million) in 2024
Figure 51. Central and South America Gene Therapy CRO Services Revenue (US$ Million) by Type (2020-2031)
Figure 52. Central and South America Gene Therapy CRO Services Revenue (US$ Million) by Application (2020-2031)
Figure 53. Brazil Gene Therapy CRO Services Revenue (2020-2025) & (US$ Million)
Figure 54. Argentina Gene Therapy CRO Services Revenue (2020-2025) & (US$ Million)
Figure 55. Middle East and Africa Gene Therapy CRO Services Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Middle East and Africa Top 5 Players Gene Therapy CRO Services Revenue (US$ Million) in 2024
Figure 57. South America Gene Therapy CRO Services Revenue (US$ Million) by Type (2020-2031)
Figure 58. Middle East and Africa Gene Therapy CRO Services Revenue (US$ Million) by Application (2020-2031)
Figure 59. GCC Countries Gene Therapy CRO Services Revenue (2020-2025) & (US$ Million)
Figure 60. Israel Gene Therapy CRO Services Revenue (2020-2025) & (US$ Million)
Figure 61. Egypt Gene Therapy CRO Services Revenue (2020-2025) & (US$ Million)
Figure 62. South Africa Gene Therapy CRO Services Revenue (2020-2025) & (US$ Million)
Figure 63. Gene Therapy CRO Services Industry Chain Mapping
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
